knowledge
Previous article:
Walensky prepares to leave CDC — and Congress — behind
Next article: The (many) problems with a new study criticizing cancer screening
Next article: The (many) problems with a new study criticizing cancer screening
knowledge
focus
-
Listen: Biogen's potential pivot, & Illumina's next chapter
2025-10-02 13:38 -
New safety details link Apellis eye drug to rare cases of blindness
2025-10-02 13:09 -
What the US credit downgrade means for the economy, your finances
2025-10-02 12:02 -
ALS advocates say criticism of new drugs misses bigger picture
2025-10-02 11:19 -
What the US credit downgrade means for the economy, your finances
2025-10-02 11:19 -
Amazon on where the company's health care bets are headed next
2025-10-02 11:01